| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2863721 | The American Journal of the Medical Sciences | 2011 | 5 Pages |
Abstract
Statin treatment was effective (without changes in liver enzymes) in patients with dyslipidemia and NAFLD and therefore, affected by a profound alteration in lipoprotein metabolism. The number of patients achieving LDL target was related to the Adult Treatment Panel III risk classification, being higher in patients with lower risk.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lorenzo MD, Luigina MD, PhD, Luana MD, Franca BcS, Sara MD, Valentina MD, Alessandra MD, Giovanni MD, Matteo MD, Anna M. MD, Marco MD, PhD, Achille MD,